Literature DB >> 26100618

Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.

Yoshinao Muro1, Kazumitsu Sugiura2, Masashi Akiyama2.   

Abstract

Dermatomyositis (DM) is a common idiopathic inflammatory myopathy. The pathogenesis is considered to be microangiopathy affecting skin and muscle. The cutaneous manifestations of DM are the most important aspect of this disease, and their correct evaluation is important for early diagnosis. The skin signs are various: Some are pathognomonic or highly characteristic, and others are compatible with DM. Recently, DM has been categorized into several disease subsets based on the various autoantibodies present in patients. Sometimes, characteristic cutaneous manifestations are strongly associated with the presence of specific autoantibodies. For example, anti-Mi-2 antibody is associated with the classic features of DM, including heliotrope rash, Gottron's papules, the V-neck sign, the shawl sign, cuticular overgrowth, and photosensitivity. Frequent cutaneous features in anti-transcriptional intermediary factor 1 gamma (TIF1γ)-positive patients are diffuse photoerythema, including "dusky red face," while skin ulcerations, palmar papules (inverse Gottron), diffuse hair loss, panniculitis, and oral pain and/or ulcers are sometimes associated with anti-melanoma differentiation-associated gene 5 product (MDA5) antibody. Here, we review important cutaneous manifestations seen in patients with DM, and we examine the relationship between the skin changes and myositis-associated autoantibodies. Correct evaluation of cutaneous manifestations and myositis-associated autoantibodies should help the clinician in the early diagnosis of DM, for a quick recognition of cutaneous signs that may be the symptom of onset before muscle inflammation.

Entities:  

Keywords:  Anti-MDA5 antibody; Anti-Mi-2 antibody; Anti-TIF1γ antibody; Cutaneous manifestation; Dermatomyositis; Myositis-associated autoantibody

Mesh:

Substances:

Year:  2016        PMID: 26100618     DOI: 10.1007/s12016-015-8496-5

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  55 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  UV radiation regulates Mi-2 through protein translation and stability.

Authors:  Craig J Burd; H Karimi Kinyamu; Frederick W Miller; Trevor K Archer
Journal:  J Biol Chem       Date:  2008-10-15       Impact factor: 5.157

3.  Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.

Authors:  Manabu Fujimoto; Yasuhito Hamaguchi; Kenzo Kaji; Takashi Matsushita; Yuki Ichimura; Masanari Kodera; Naoko Ishiguro; Ikuko Ueda-Hayakawa; Yoshihide Asano; Fumihide Ogawa; Keita Fujikawa; Takuya Miyagi; Eriko Mabuchi; Kenji Hirose; Narihiro Akimoto; Naohito Hatta; Kiyohiro Tsutsui; Akira Higashi; Atsuyuki Igarashi; Mariko Seishima; Minoru Hasegawa; Kazuhiko Takehara
Journal:  Arthritis Rheum       Date:  2012-02

4.  Inverse Gottron's papules: an unusual cutaneous manifestation of juvenile dermatomyositis.

Authors:  Suzanne D Quinter; Yvonne E Chiu; Valerie B Lyon; Kristen E Holland; Sun Young Ruggeri; Beth A Drolet
Journal:  Pediatr Dermatol       Date:  2011-12-30       Impact factor: 1.588

5.  Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.

Authors:  Hideto Kameda; Hayato Nagasawa; Hiroe Ogawa; Naoya Sekiguchi; Hirofumi Takei; Michihide Tokuhira; Koichi Amano; Tsutomu Takeuchi
Journal:  J Rheumatol       Date:  2005-09       Impact factor: 4.666

6.  Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.

Authors:  H Gunawardena; L R Wedderburn; J North; Z Betteridge; J Dunphy; H Chinoy; J E Davidson; R G Cooper; N J McHugh
Journal:  Rheumatology (Oxford)       Date:  2008-01-30       Impact factor: 7.580

7.  Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects.

Authors:  L Dourmishev; H Meffert; H Piazena
Journal:  Photodermatol Photoimmunol Photomed       Date:  2004-10       Impact factor: 3.135

8.  Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.

Authors:  Stéphanie Christen-Zaech; Roopa Seshadri; Joyce Sundberg; Amy S Paller; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2008-02

Review 9.  The diagnostic utility of autoantibodies in adult and juvenile myositis.

Authors:  Sarah L Tansley; Zoe E Betteridge; Neil J McHugh
Journal:  Curr Opin Rheumatol       Date:  2013-11       Impact factor: 5.006

10.  Autoantibodies in systemic autoimmune disorders.

Authors:  Michael Mahler; Silvia Pierangeli; Pier-Luigi Meroni; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-06-30       Impact factor: 4.818

View more
  32 in total

Review 1.  Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.

Authors:  Jian-Qiang Wu; Mei-Ping Lu; Ann M Reed
Journal:  World J Pediatr       Date:  2019-09-26       Impact factor: 2.764

Review 2.  Classification of myositis.

Authors:  Ingrid E Lundberg; Marianne de Visser; Victoria P Werth
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

Review 3.  Diagnostic Imaging of Inflammatory Myopathies: New Concepts and a Radiological Approach.

Authors:  Júlio Brandão Guimarães; Marcelo A Nico; Alípio G Omond; Laís Uyeda Aivazoglou; Rafael Baches Jorge; Edmar Zanoteli; Artur R C Fernandes
Journal:  Curr Rheumatol Rep       Date:  2019-02-14       Impact factor: 4.592

Review 4.  Scalp Itch: A Systematic Review.

Authors:  Norma Elizabeth Vázquez-Herrera; Divya Sharma; Nouf Mohammed Aleid; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2017-11-29

5.  Panniculitis as an Initial Presentation of Dermatomyositis: A Case Report.

Authors:  Anjal Bisht; Niraj Parajuli; Monasha Vaidya; Sumida Tiwari
Journal:  JNMA J Nepal Med Assoc       Date:  2020-03       Impact factor: 0.406

Review 6.  Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.

Authors:  Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 7.  Autoimmunity in 2016.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

8.  Inverse Gottron papules in juvenile dermatomyositis: an under recognized clinical entity.

Authors:  Ankur Kumar Jindal; Sandesh Guleria; Rakesh Kumar Pilania; Anuradha Bishnoi; Keshavamurthy Vinay; Sunil Dogra; Deepti Suri; Amit Rawat; Surjit Singh
Journal:  Rheumatol Int       Date:  2018-05-02       Impact factor: 2.631

9.  The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy.

Authors:  Ya-Mei Zhang; Han-Bo Yang; Jing-Li Shi; He Chen; Xiao-Ming Shu; Xin Lu; Guo-Chun Wang; Qing-Lin Peng
Journal:  Clin Rheumatol       Date:  2018-03-15       Impact factor: 2.980

10.  Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositis.

Authors:  Zoltan Griger; Katalin Danko; Gabor Nemeth; Ziad Hassan; Zsuzsa Aszalos; Katalin Szabo; Levente Bodoki; Rudolf Gesztelyi; Judit Zsuga; Peter Szodoray; Adam Kemeny-Beke
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.